Loading Events

  • This event has passed.

Mr. Flanzraich is the Chairman and CEO of Cantex Pharmaceuticals, Inc. a biotech company developing novel therapies for cancer. He is a member of the boards of directors of Chipotle Mexican Grill, Inc. (CMG:NYSE), a chain of casual fast food restaurants, and Equity One, Inc. (EQY:NYSE), a REIT specializing in shopping centers. Mr. Flanzraich served as the Vice Chairman and President of Ivax Corporation, an international pharmaceutical company, which was sold to Teva in 2006 for an enterprise value of $10 Billion. He was also the Chairman of North American Vaccine, Inc., and has served as a director for many health science industry corporations. He has also consulted for private equity firms and institutional investors on pharmaceutical transactions and investments.

Industry Knowledge: Pharmaceutical Industry, Private Equity Consulting, Medical Industry Products, Corporate Management, Biotech

Sign up here to meet with Neil Flanzraich at Harvard i-lab.


October 24, 2017
10:00 am - 2:00 pm
Event Category:
OCS Program


Cyberlaw Clinic & OCS
Cyberlaw Clinic
Office of Career Services


i-Lab (HBS)
Batten Hall - 125 Western Ave.
Boston, MA
+ Google Map